Furthermore, the cleaved caspase-3 staining confirmed a five-fold increase in apoptosis in the tumor sections from the group treated with rocaglamide, relative to the untreated control (Fig. 5C, bottom panels and D, lower panel). Here, CASP3 is linked to neoplasm.